Proatherogenic modification of LDL by surface-bound myeloperoxidase

Chemistry and Physics of Lipids

Volumn 180, Issue , 2014, Pages 72-80

  Sokolov, Alexej V ^a,b,c   Kostevich, Valeria A ^a,b   Runova, Olga L ^a   Gorudko, Irina V ^d   Vasilyev, Vadim B ^a,c   Cherenkevich, Sergej N ^d   Panasenko, Oleg M ^b  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b FEDERAL RESEARCH AND CLINICAL CENTER OF PHYSICAL CHEMICAL MEDICINE OF FEDERAL MEDICAL BIOLOGICAL AGENCY   (Russian Federation)

^c ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

^d BELARUSIAN STATE UNIVERSITY   (Belarus)

Author keywords

Atherosclerosis; Cholesterol accumulation; Low density lipoproteins; Myeloperoxidase; Oxidative halogenative stress; Reactive halogen species

Indexed keywords

4 AMINOBENZOIC ACID; ANTILIPEMIC AGENT; APOLIPOPROTEIN B100; APOLIPOPROTEIN B100[445-456]; CERULOPLASMIN; CHOLESTEROL; HALIDE; HYDRAZIDE; HYDROGEN PEROXIDE; LOW DENSITY LIPOPROTEIN; MYELOPEROXIDASE; PEPTIDE DERIVATIVE; THIOCYANATE; UNCLASSIFIED DRUG;

ARTICLE; ATHEROGENESIS; BINDING AFFINITY; CELL DIFFERENTIATION; COMPLEX FORMATION; CONTROLLED STUDY; DEGRANULATION; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME RELEASE; HALOGENATION; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; MACROPHAGE; MONOCYTE; NORMAL HUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; SURFACE PROPERTY;

ATHEROSCLEROSIS; CHOLESTEROL ACCUMULATION; LOW DENSITY LIPOPROTEINS; MYELOPEROXIDASE; OXIDATIVE/HALOGENATIVE STRESS; REACTIVE HALOGEN SPECIES;

AMINO ACID SEQUENCE; ANIMALS; APOLIPOPROTEIN B-100; ATHEROSCLEROSIS; BINDING SITES; CHOLESTEROL; ENDOCYTOSIS; EXOCYTOSIS; HUMANS; INTRACELLULAR SPACE; LIPOPROTEINS, LDL; MACROPHAGES; MONOCYTES; PEPTIDE FRAGMENTS; PEROXIDASE; PROTEIN BINDING;

EID: 84897989832     PISSN: 00093084     EISSN: 18732941     Source Type: Journal    
DOI: 10.1016/j.chemphyslip.2014.02.006     Document Type: Article

References (56)

1. Z. Bahadoran, P. Mirmiran, F. Hosseinpanah, A. Rajab, G. Asghari, and F. Azizi Broccoli sprouts powder could improve serum triglyceride and oxidized LDL/LDL-cholesterol ratio in type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial Diabetes Res. Clin. Pract. 96 2012 348 354
2. S. Baldus, C. Heeschen, T. Meinertz, A.M. Zeiher, J.P. Eiserich, T. Münzel, M.L. Simoons, and C.W. Hamm Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes Circulation 108 2003 1440 1445
3. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
4. A.C. Carr, E.A. Decker, Y. Park, and B. Frei Comparison of low-density lipoprotein modification by myeloperoxidase-derived hypochlorous and hypobromous acids Free Radic. Biol. Med. 31 2001 62 72
5. J.D. Chandler, and B.J. Day Thiocyanate: a potentially useful therapeutic agent with host defense and antioxidant properties Biochem. Pharmacol. 84 2012 1381 1387
6. A.L. Chapman, T.J. Mocatta, S. Shiva, A. Seidel, B. Chen, I. Khalilova, M.E. Paumann-Page, G.N. Jameson, C.C. Winterbourn, and A.J. Kettle Ceruloplasmin is an endogenous inhibitor of myeloperoxidase J. Biol. Chem. 288 2013 6465 6477
7. M.J. Davies, C.L. Hawkins, D.I. Pattison, and M.D. Rees Mammalian heme peroxidases: from molecular mechanisms to health implications Antioxid. Redox Signal. 10 2008 1199 1234
8. B.J. Davis Disc electrophoresis. II. Method and application to human serum proteins Ann. N. Y. Acad. Sci. 121 1964 404 427
9. A. Daugherty, J.L. Dunn, D.L. Rateri, and J.W. Heinecke Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions J. Clin. Invest. 94 1994 437 444
10. G. Deby-Dupont, C. Deby, and M. Lamy Neutrophil myeloperoxidase revisited: it's role in health and disease Intensivmed 36 1999 500 513
11. M.C. Delporte, P. Van Antwerpen, L. Vanhamme, T. Roumeguère, and K. Zouaoui Boudjeltia Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies Mediators Inflamm. 2013 971579 10.1155/2013/971579
12. M. Exner, M. Hermann, R. Hofbauer, B. Hartmann, S. Kapiotis, and B. Gmeiner Thiocyanate catalyzes myeloperoxidase-initiated lipid oxidation in LDL Free Radic. Biol. Med. 37 2004 146 155
13. -: formation of bromochloramines Inorg. Chem. 33 1994 118 123
14. I.V. Gorudko, D.V. Grigorieva, E.V. Shamova, V.A. Kostevich, A.V. Sokolov, E.V. Mikhalchik, S.N. Cherenkevich, J. Arnhold, and O.M. Panasenko Hypohalous acid-modified human serum albumin induces neutrophil NADPH oxidase activation, degranulation, and shape change Free Radic. Biol. Med. 68 2014 326 334 10.1016/j.freeradbiomed.2013.12.023
15. I.V. Gorudko, O.S. Tcherkalina, A.V. Sokolov, M.O. Pulina, E.T. Zakharova, V.B. Vasilyev, S.N. Cherenkevich, and O.M. Panasenko New approaches to the measurements of the concentration and peroxidase activity of myeloperoxidase in human blood plasma Russ. J. Bioorg. Chem. 35 2009 566 575
16. I.V. Gorudko, T.V. Vakhrusheva, A.V. Mukhortova, S.N. Cherenkevich, A.V. Timoshenko, V.I. Sergienko, and V.I. Panasenko The priming effect of halogenated phospholipids on the functional responses of human neutrophils Biochemistry (Moscow). Suppl. Series A: Memb. Cell Biol. 4 2010 262 271
17. L.J. Hazell, L. Arnold, D. Flowers, G. Waeg, E. Malle, and R. Stocker Presence of hypochlorite-modified proteins in human atherosclerotic lesions J. Clin. Invest. 97 1996 1535 1544
18. L.J. Hazell, G. Baernthaler, and R. Stocker Correlation between intima-to-media ratio, apolipoprotein B-100, myeloperoxidase, and hypochlorite-oxidized proteins in human atherosclerosis Free Radic. Biol. Med. 31 2001 1254 1262
19. S.L. Hazen, and J.W. Heinecke 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima J. Clin. Invest. 99 1997 2075 2081
20. S.J. Klebanoff Myeloperoxidase: friend and foe J. Leukoc. Biol. 77 2005 598 625
21. S. Kopprasch, W. Leonhardt, J. Pietzsch, and H. Kühne Hypochlorite-modified low-density lipoprotein stimulates human polymorphonuclear leukocytes for enhanced production of reactive oxygen metabolites, enzyme secretion, and adhesion to endothelial cells Atherosclerosis 136 1998 315 324
22. V.I. Krupyanko Corrected equations for calculation of constants in enzyme inhibition and activation Biochemistry (Moscow) 72 2007 380 391
23. K. Kumar, and D.W. Margerum Kinetics and mechanism of general acid-assisted oxidation of bromide by hypochlorite and hypochlorous acid Inorg. Chem. 26 1987 2706 2711
24. J. MacLachlan, A.T. Wotherspoon, R.O. Ansell, and C.J. Brooks Cholesterol oxidase: sources, physical properties and analytical applications J. Steroid Biochem. Mol. Biol. 72 2000 169 195
25. E. Malle, G. Marsche, J. Arnhold, and M.J. Davies Modification of low-density lipoprotein by myeloperoxidase-derived oxidants and reagent hypochlorous acid Biochim. Biophys. Acta 1761 2006 392 415
26. G. Marsche, P.G. Furtmüller, C. Obinger, W. Sattler, and E. Malle Hypochlorite-modified high-density lipoprotein acts as a sink for myeloperoxidase in vitro Cardiovasc. Res. 79 2008 187 194
27. G. Marsche, A. Hammer, O. Oskolkova, K.F. Kozarsky, W. Sattler, and E. Malle Hypochlorite-modified high density lipoprotein, a high affinity ligand to scavenger receptor class B, type I, impairs high density lipoprotein-dependent selective lipid uptake and reverse cholesterol transport J. Biol. Chem. 277 2002 32172 32179
28. M.C. Messner, C.J. Albert, J. McHowat, and D.A. Ford Identification of lysophosphatidylcholine-chlorohydrin in human atherosclerotic lesions Lipids 43 2008 243 249
29. J.C. Morris The acid ionisation constant of HOCl from 5° to 35° J. Phys. Chem. 195 1966 133 140
30. T. Nguyen-Khoa, Z.A. Massy, V. Witko-Sarsat, S. Canteloup, M. Kebede, B. Lacour, T. Drüeke, and B. Descamps-Latscha Oxidized low-density lipoprotein induces macrophage respiratory burst via its protein moiety: a novel pathway in atherogenesis? Biochem. Biophys. Res. Commun. 263 1999 804 809
31. S.J. Nicholls, and S.L. Hazen Myeloperoxidase, modified lipoproteins and atherogenesis J. Lipid Res. 50 Suppl. S 2009 346 351
32. O.M. Panasenko The mechanism of the hypochlorite-induced lipid peroxidation Biofactors 6 1997 181 190
33. O.M. Panasenko, K. Briviba, L.-O. Klotz, and H. Sies Oxidative modification and nitration of human low-density lipoproteins by the reaction of hypochlorous acid with nitrite Arch. Biochem. Biophys. 343 1997 254 259
34. O.M. Panasenko, A.V. Chekanov, I.I. Vlasova, A.V. Sokolov, K.V. Ageeva, M.O. Pulina, O.S. Cherkalina, and V.B. Vasil'ev A study of the effect of ceruloplasmin and lactoferrin on the chlorination activity of leukocytic myeloperoxidase using the chemiluminescence method Biophysics 53 2008 268 272
35. - Free Radic. Biol. Med. 16 1994 143 148
36. O.M. Panasenko, S.A. Evgina, E.S. Driomina, V.S. Sharov, V.I. Sergienko, and A. Yu. Vladimirov Hypochlorite induces lipid peroxidation in blood lipoproteins and phospholipid liposomes Free Radic. Biol. Med. 19 1995 133 140
37. O.M. Panasenko, I.V. Gorudko, and A.V. Sokolov Hypochlorous acid as a precursor of free radicals in living systems Biochemistry (Moskow) 78 2013 1466 1489
38. O.M. Panasenko, T.V. Vol'nova, A.N. Osipov, O.A. Azizova, and Yu.A. Vladimirov Free-radical generation by monocytes and neutrophils: a possible cause of plasma lipoprotein modification Biomed. Sci. 2 1991 581 589
39. O.M. Panasenko, S.A. Yevgina, S.V. Nikitin, and V.I. Sergienko Effect of hypochlorite on the electrical properties of the surface of human blood lipoproteins Biophysics 40 1995 531 536
40. V.R. Samygina, A.V. Sokolov, G. Bourenkov, M.V. Petoukhov, M.O. Pulina, E.T. Zakharova, V.B. Vasilyev, H. Bartunik, and D.I. Svergun Ceruloplasmin: macromolecular assemblies with iron-containing acute phase proteins PLoS ONE 8 2013 e67145
41. J. Schultz, and K. Kaminker Myeloperoxidase of the leucocyte of normal human blood. 1. Content and localization Arch. Biochem. Biophys. 96 1962 465 467
42. M. Segelmark, B. Persson, T. Hellmark, and J. Wieslander Binding and inhibition of myeloperoxidase (MPO): a major function of ceruloplasmin? Clin. Exp. Immunol. 108 1997 167 174
43. A.V. Sokolov, K.V. Ageeva, M.O. Pulina, O.S. Cherkalina, V.R. Samygina, I.I. Vlasova, O.M. Panasenko, E.T. Zakharova, and V.B. Vasilyev Ceruloplasmin and myeloperoxidase in complex affect the enzymatic properties of each other Free Radic. Res. 42 2008 989 998
44. A.V. Sokolov, K.V. Ageeva, O.S. Cherkalina, M.O. Pulina, E.T. Zakharova, V.N. Prozorovskii, D.V. Aksenov, V.B. Vasilyev, and O.M. Panasenko Identification and properties of complexes formed by myeloperoxidase with lipoproteins and ceruloplasmin Chem. Phys. Lipids 163 2010 347 355
45. A.V. Sokolov, A.V. Chekanov, V.A. Kostevich, D.V. Aksenov, V.B. Vasilyev, and O.M. Panasenko Revealing binding sites for myeloperoxidase on the surface of human low density lipoproteins Chem. Phys. Lipids 164 2011 49 53
46. A.V. Sokolov, V.A. Kostevich, D.N. Romanico, E.T. Zakharova, and V.B. Vasilyev Two-stage method for purification of ceruloplasmin based on its interaction with neomycin Biochemistry (Moscow) 77 2012 631 638
47. A.V. Sokolov, M.O. Pulina, K.V. Ageeva, M.I. Ayrapetov, M.N. Berlov, G.N. Volgin, A.G. Markov, P.K. Yablonsky, N.I. Kolodkin, E.T. Zakharova, and V.B. Vasilyev Interaction of ceruloplasmin, lactoferrin, and myeloperoxidase Biochemistry (Moscow) 72 2007 409 415
48. D. Steinberg Atherogenesis in perspective: hypercholesteremia and inflammation as partners in crime Nat. Med. 8 2002 1211 1217
49. J. Takeshita, J. Byun, T.Q. Nhan, D.K. Pritchard, S. Pennathur, S.M. Schwartz, A. Chait, and J.W. Heinecke Myeloperoxidase generates 5-chlorouracil in human atherosclerotic tissue: a potential pathway for somatic mutagenesis by macrophages J. Biol. Chem. 281 2006 3096 3104
50. A.K. Thukkani, J. McHowat, F.F. Hsu, M.L. Brennan, S.L. Hazen, and D.A. Ford Identification of alpha-chloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions Circulation 108 2003 3128 3133
51. 2 and granule enzyme release from cells Methods Mol. Med. 9 1998 441 451
52. T. Tomofuji, D. Ekuni, T. Azuma, K. Irie, Y. Endo, T. Yamamoto, A. Ishikado, T. Sato, K. Harada, H. Suido, and M. Morita Supplementation of broccoli or Bifidobacterium longum-fermented broccoli suppresses serum lipid peroxidation and osteoclast differentiation on alveolar bone surface in rats fed a high-cholesterol diet Nutr. Res. 32 2012 301 307
53. C.J. van Dalen, M.W. Whitehouse, C.C. Winterbourn, and A.J. Kettle Thiocyanate and chloride as competing substrates for myeloperoxidase Biochem. J. 327 1997 487 492
54. A.M. van der Does, P.J. Hensbergen, S.J. Bogaards, M. Cansoy, A.M. Deelder, H.C. van Leeuwen, J.W. Drijfhout, J.T. van Dissel, and P.H. Nibbering The human lactoferrin-derived peptide hLF1-11 exerts immunomodulatory effects by specific inhibition of myeloperoxidase activity J. Immunol. 188 2012 5009 5012
55. V. Witko-Sarsat, V. Gausson, A.T. Nguyen, M. Touam, T. Drüeke, F. Santangelo, and B. Descamps-Latscha AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: a potential target for N-acetylcysteine treatment in dialysis patients Kidney Int. 64 2003 82 91
56. L. Zheng, B. Nukuna, M.L. Brennan, M. Sun, M. Goormastic, M. Settle, D. Schmitt, X. Fu, L. Thomson, P.L. Fox, H. Ischiropoulos, J.D. Smith, M. Kinter, and S.L. Hazen Apolipoprotein A-I is a selective target for myeloperoxidase- catalyzed oxidation and functional impairment in subjects with cardiovascular disease J. Clin. Invest. 114 2004 529 541